Search for: "Ortho-McNeil Janssen Pharmaceuticals Inc" Results 1 - 20 of 76
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
18 Apr 2011, 1:12 pm by Mark Zamora
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. [read post]
29 Apr 2010, 2:06 am by Ben Vernia
The Department of Justice announced on April 29 that Ortho-McNeil Pharmaceutical, LLC, and Ortho-McNeil-Janssen Pharmaceuticals, Inc., two subsidiaries of Johnson & Johnson, have agreed to pay $81 million to settle charges brought in two whistleblower suits that they violated the False Claims Act by promoting Topamax for off-label (unapproved) uses. [read post]
20 Jun 2011, 7:47 am by info@thomasjhenrylaw.com
Ortho-McNeil-Janssen Pharmaceuticals, Inc., a member of the Johnson and Johnson family, has issued a recall of about 40,000 bottles of Risperdal and its generic form. [read post]
18 May 2010, 7:03 pm by Carey, Danis & Lowe
A recent $81 million settlehttp://www.jefflowepc.com/lawyer-attorney-1176136.htmlment between the Department of Justice and Johnson & Johnson's Ortho-McNeil Janssen Pharmaceuticals Inc. means sales reps for the company will be monitored with compliance officers who will observe and report on the representatives' behavior on the job. [read post]
23 Feb 2010, 9:01 pm by Patent Docs
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
13 May 2010, 4:57 pm by mcarzima@imediainc.com
Two subsidiaries of Johnson & Johnson, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., have agreed to pay more than $81 million to settle allegations that they violated the False Claims Act by illegally promoting the epilepsy drug, Topomax. [read post]
23 May 2011, 9:59 pm by Patent Docs
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
3 Oct 2011, 9:28 pm by Barry Barnett
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 11-2070 (7th Cir. [read post]
10 Dec 2015, 8:00 pm by John Ehrett
The petition of the day is: Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
8 Jan 2010, 11:40 am by Mark Zamora
The drugs are made by Janssen, a division of Ortho-McNeil-Janssen Pharmaceuticals Inc., which is part of Johnson & Johnson. [read post]
25 Jan 2010, 8:42 pm by LaBovick Law
The United States filed a qui tam or False Claims Act complaint against Johnson & Johnson (J&J) and its subsidiary companies Johnson & Johnson Health Care Systems Inc. and Ortho-McNeil-Janssen Pharmaceuticals Inc. [read post]
4 Feb 2009, 4:09 pm
  Product liability cases against large conglomerates like Ortho-McNeil-Janssen Pharmaceuticals, Inc., can often be more than most attorneys can handle. [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
A South Carolina judge has ordered Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit to pay the state of South Carolina $327 million for deceptive marketing of their anti-psychotic drug, Risperdal. [read post]
2 Sep 2020, 1:45 pm by Tom Lamb
JOHNSON & JOHNSON d/b/a Alza Corporation, d/b/a Janssen Ortho LLC, d/b/a Janssen Research & Development LLC, d/b/a Ortho-McNeil Pharmaceuticals, Inc. [read post]